Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,932 | -18,389 | -9,793 | -35,910 | -26,652 |
| Depreciation Amortization | 2,388 | 1,560 | 733 | 1,125 | 412 |
| Accounts receivable | -8,455 | -6,831 | -2,666 | -444 | -679 |
| Accounts payable and accrued liabilities | -1,447 | -1,206 | 272 | 2,987 | 1,341 |
| Other Working Capital | -9,579 | -8,383 | -4,328 | 5,078 | 4,607 |
| Other Operating Activity | 553 | 5,595 | 1,080 | 2,863 | 5,820 |
| Operating Cash Flow | $-36,472 | $-27,654 | $-14,702 | $-24,301 | $-15,151 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -370 | -337 | -160 | -842 | -163 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -25,000 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -25,000 | 0 |
| Investing Cash Flow | $-370 | $-337 | $-160 | $-25,842 | $-163 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 35,000 | 35,000 |
| Debt Repayment | -207 | -150 | -3 | -4,871 | -4,868 |
| Common Stock Issued | 320 | 180 | 125 | 38,372 | 38,252 |
| Other Financing Activity | -327 | -327 | -327 | 46,244 | -3,651 |
| Financing Cash Flow | $-214 | $-297 | $-205 | $114,745 | $64,733 |
| Exchange Rate Effect | -301 | -273 | -302 | -533 | -623 |
| Beginning Cash Position | 76,697 | 76,697 | 76,697 | 12,628 | 12,628 |
| End Cash Position | 39,340 | 48,136 | 61,328 | 76,697 | 61,424 |
| Net Cash Flow | $-37,357 | $-28,561 | $-15,369 | $64,069 | $48,796 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,472 | -27,654 | -14,702 | -24,301 | -15,151 |
| Capital Expenditure | -370 | -337 | -160 | -842 | -163 |
| Free Cash Flow | -36,842 | -27,991 | -14,862 | -25,143 | -15,314 |